Lumos Pharma (LUMO) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Lumos Pharma Revenue Highlights

Latest Revenue (Y)

$2.05M

Latest Revenue (Q)

$488.00K

Main Segment (Y)

Royalty

Lumos Pharma Revenue by Period

Lumos Pharma Revenue by Year

Date	Revenue	Change
2023-12-31	$2.05M	34.67%
2022-12-31	$1.52M	562.17%
2021-12-31	$230.00K	36.90%
2020-12-31	$168.00K	-82.05%
2019-12-31	$936.00K	-22.39%
2018-12-31	$1.21M	209.23%
2017-12-31	$390.00K	-88.94%
2016-12-31	$3.53M	-90.24%
2015-12-31	$36.14M	-78.22%
2014-12-31	$165.95M	15082.98%
2013-12-31	$1.09M	-35.21%
2012-12-31	$1.69M	-9.88%
2011-12-31	$1.87M	-9.96%
2010-12-31	$2.08M	122.59%
2009-12-31	$934.00K	47.55%
2008-12-31	$633.00K	-

Lumos Pharma generated $2.05M in revenue during NA 2023, up 34.67% compared to the previous quarter, and up 170.07% compared to the same period a year ago.

Lumos Pharma Revenue by Quarter

Date	Revenue	Change
2024-06-30	$488.00K	195.76%
2024-03-31	$165.00K	-80.02%
2023-12-31	$826.00K	11700.00%
2023-09-30	$7.00K	-98.67%
2023-06-30	$527.00K	-23.73%
2023-03-31	$691.00K	34.96%
2022-12-31	$512.00K	3.02%
2022-09-30	$497.00K	23.33%
2022-06-30	$403.00K	263.06%
2022-03-31	$111.00K	-49.55%
2021-12-31	$220.00K	100.00%
2021-09-30	-	-100.00%
2021-06-30	$10.00K	100.00%
2021-03-31	-	-100.00%
2020-12-31	$40.00K	-45.95%
2020-09-30	$74.00K	124.24%
2020-06-30	$33.00K	57.14%
2020-03-31	$21.00K	-95.15%
2019-12-31	$433.00K	76.02%
2019-09-30	$246.00K	62.91%
2019-06-30	$151.00K	42.45%
2019-03-31	$106.00K	-47.52%
2018-12-31	$202.00K	68.33%
2018-09-30	$120.00K	-94.67%
2018-06-30	$2.25M	-77.25%
2018-03-31	$9.90M	17578.57%
2017-12-31	$56.00K	-45.63%
2017-09-30	$103.00K	-99.01%
2017-06-30	$10.37M	275.59%
2017-03-31	$2.76M	433.01%
2016-12-31	$518.00K	-41.67%
2016-09-30	$888.00K	-55.86%
2016-06-30	$2.01M	-64.75%
2016-03-31	$5.71M	-25.41%
2015-12-31	$7.65M	-46.15%
2015-09-30	$14.21M	90.85%
2015-06-30	$7.45M	-81.01%
2015-03-31	$39.20M	-76.84%
2014-12-31	$169.25M	5942.31%
2014-09-30	$2.80M	1221.23%
2014-06-30	$212.00K	-36.53%
2014-03-31	$334.00K	13.61%
2013-12-31	$294.00K	10.94%
2013-09-30	$265.00K	14.22%
2013-06-30	$232.00K	-23.18%
2013-03-31	$302.00K	1.00%
2012-12-31	$299.00K	-8.56%
2012-09-30	$327.00K	-44.58%
2012-06-30	$590.00K	25.27%
2012-03-31	$471.00K	56.48%
2011-12-31	$301.00K	-80.84%
2011-09-30	$1.57M	192.55%
2011-06-30	$537.00K	-11.09%
2011-03-31	$604.00K	-37.99%
2010-12-31	$974.00K	159.73%
2010-09-30	$375.00K	-43.69%
2009-12-31	$666.00K	-

Lumos Pharma generated $488.00K in revenue during Q2 2024, up 195.76% compared to the previous quarter, and up 70.62% compared to the same period a year ago.

Lumos Pharma Revenue Breakdown

Lumos Pharma Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20
Royalty	$2.00M	$1.50M	$220.00K	-
License and Service	-	-	$10.00K	$168.00K

Lumos Pharma's latest annual revenue breakdown by segment (product or service), as of Dec 23: Royalty (100.00%).

Quarterly Revenue by Product

Product/Service	Sep 24	Jun 24	Mar 24	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Jun 21	Dec 20	Sep 20	Jun 20	Mar 20	Sep 19	Jun 19	Mar 19
Royalty	$700.00K	$500.00K	$200.00K	$800.00K	$500.00K	$700.00K	$500.00K	$500.00K	$400.00K	$111.00K	-	-	-	-	-	-	-	-
License and Service	-	-	-	-	-	-	-	-	-	-	$10.00K	$40.00K	$74.00K	$33.00K	$21.00K	$246.00K	$151.00K	$106.00K
Grant	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Lumos Pharma's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Royalty (100.00%).

Lumos Pharma Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
IPSC	Century Therapeutics	$2.23M	$791.00K
LUMO	Lumos Pharma	$2.05M	$488.00K
STTK	Shattuck Labs	$1.66M	$1.61M
SILO	Silo Pharma	$72.10K	$18.02K
ANEB	Anebulo Pharmaceuticals	-	-
RZLT	Rezolute	-	-
FBRX	Forte Biosciences	-	-
ERAS	Erasca	-	-
ELYM	Eliem Therapeutics	-	-
PRDS	Pardes Biosciences	-	-
CSBR	Champions Oncology	-	-

LUMO Revenue FAQ

What is Lumos Pharma’s yearly revenue?

Lumos Pharma's yearly revenue for 2023 was $2.05M, representing an increase of 34.67% compared to 2022. The company's yearly revenue for 2022 was $1.52M, representing an increase of 562.17% compared to 2021. LUMO's yearly revenue for 2021 was $230K, representing an increase of 36.90% compared to 2020.

What is Lumos Pharma’s quarterly revenue?

Lumos Pharma's quarterly revenue for Q2 2024 was $488K, a 195.76% increase from the previous quarter (Q1 2024), and a -7.40% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $165K, a -80.02% decrease from the previous quarter (Q4 2023), and a -76.12% decrease year-over-year (Q1 2023). LUMO's quarterly revenue for Q4 2023 was $826K, a 11700.00% increase from the previous quarter (Q3 2023), and a 61.33% increase year-over-year (Q4 2022).

What is Lumos Pharma’s revenue growth rate?

Lumos Pharma's revenue growth rate for the last 3 years (2021-2023) was 791.74%, and for the last 5 years (2019-2023) was 119.12%.

What are Lumos Pharma’s revenue streams?

Lumos Pharma's revenue streams in c 23 are Royalty

What is Lumos Pharma’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Lumos Pharma was Royalty. This segment made a revenue of $2M, representing 100.00% of the company's total revenue.